These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18294153)

  • 1. Long-term outcome of early steroid withdrawal after kidney transplantation in African American recipients monitored by surveillance biopsy.
    Anil Kumar MS; Khan S; Ranganna K; Malat G; Sustento-Reodica N; Meyers WC
    Am J Transplant; 2008 Mar; 8(3):574-85. PubMed ID: 18294153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avoidance of chronic steroid therapy in african american kidney transplant recipients monitored by surveillance biopsy: 1-year results.
    Anil Kumar MS; Moritz MJ; Saaed MI; Heifets M; Sustento-Reodica N; Fyfe B; Kumar A
    Am J Transplant; 2005 Aug; 5(8):1976-85. PubMed ID: 15996248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermediate-term outcomes with early steroid withdrawal in African-American renal transplant recipients undergoing surveillance biopsy.
    Zeng X; El-Amm JM; Doshi MD; Singh A; Morawski K; Cincotta E; Losanoff JE; West MS; Gruber SA
    Surgery; 2007 Oct; 142(4):538-44; discussion 544-5. PubMed ID: 17950346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of steroid withdrawal two days after kidney transplantation: analysis of results at three years.
    Kumar MS; Heifets M; Moritz MJ; Saeed MI; Khan SM; Fyfe B; Sustento-Riodeca N; Daniel JN; Kumar A
    Transplantation; 2006 Mar; 81(6):832-9. PubMed ID: 16570004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of simultaneous kidney-pancreas transplantation in African-American recipients: a case-control study.
    Lo A; Stratta RJ; Egidi MF; Shokouh-Amiri MH; Grewal HP; Kizilisik AT; Alloway RR; Gaber LW; Gaber AO
    Clin Transplant; 2000 Dec; 14(6):572-9. PubMed ID: 11127311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients.
    Montero N; Webster AC; Royuela A; Zamora J; Crespo Barrio M; Pascual J
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD007669. PubMed ID: 25220222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 39-month follow-up study to evaluate the safety and efficacy in kidney transplant recipients treated with modified-release tacrolimus (FK506E)-based immunosuppression regimen.
    Han DJ; Park JB; Kim YS; Kim SJ; Ha J; Kim HC; Kim SJ; Moon IS; Yang CW
    Transplant Proc; 2012 Jan; 44(1):115-7. PubMed ID: 22310592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic evaluation of short-term outcome after early corticosteroid discontinuation in kidney transplantation.
    Miura M; Ogawa Y; Kubota KC; Harada H; Shimoda N; Seki T; Hirano T; Nonomura K
    Clin Transplant; 2009 Aug; 23 Suppl 20():10-6. PubMed ID: 19594589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of steroid avoidance in tacrolimus/mycophenolate mofetil and tacrolimus/sirolimus combination in kidney transplantation monitored by surveillance biopsy.
    Anil Kumar MS; Heifets M; Fyfe B; Saaed MI; Moritz MJ; Parikh MH; Kumar A
    Transplantation; 2005 Sep; 80(6):807-14. PubMed ID: 16210969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients.
    Włodarczyk Z; Wałaszewski J; Perner F; Vitko S; Ostrowski M; Bachleda P; Kokot F; Klinger M; Szenohradsky P; Studenik P; Navratil P; Asztalos L; Rutkowski B; Nagy KK; Hickey D
    Ann Transplant; 2002; 7(3):28-31. PubMed ID: 12465429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term experience with early steroid withdrawal in African-American renal transplant recipients.
    Haririan A; Sillix DH; Morawski K; El-Amm JM; Garnick J; Doshi MD; West MS; Gruber SA
    Am J Transplant; 2006 Oct; 6(10):2396-402. PubMed ID: 16869806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid avoidance or withdrawal for kidney transplant recipients.
    Haller MC; Royuela A; Nagler EV; Pascual J; Webster AC
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD005632. PubMed ID: 27546100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial.
    Thomusch O; Wiesener M; Opgenoorth M; Pascher A; Woitas RP; Witzke O; Jaenigen B; Rentsch M; Wolters H; Rath T; Cingöz T; Benck U; Banas B; Hugo C
    Lancet; 2016 Dec; 388(10063):3006-3016. PubMed ID: 27871759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: a single center and UNOS analysis. United Network for Organ Sharing.
    Sarwal MM; Cecka JM; Millan MT; Salvatierra O
    Transplantation; 2000 Dec; 70(12):1728-36. PubMed ID: 11152105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary results with early corticosteroid withdrawal in African American renal allograft recipients.
    Gruber SA; West MS; Sillix DH; El-Amm JM; Garnick J; Morawski K; Haririan A
    Surgery; 2005 Oct; 138(4):772-8; discussion 778-9. PubMed ID: 16269308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression.
    Boardman RE; Alloway RR; Alexander JW; Buell JF; Cardi M; First MR; Hanaway MJ; Munda R; Rogers CC; Roy-Chaudhury P; Susskind B; Trofe J; Woodle ES
    Am J Transplant; 2005 Feb; 5(2):356-65. PubMed ID: 15643996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation.
    Sarwal MM; Yorgin PD; Alexander S; Millan MT; Belson A; Belanger N; Granucci L; Major C; Costaglio C; Sanchez J; Orlandi P; Salvatierra O
    Transplantation; 2001 Jul; 72(1):13-21. PubMed ID: 11468528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term graft outcomes after steroid withdrawal in African American kidney transplant recipients receiving sirolimus and tacrolimus.
    Hricik DE; Augustine JJ; Knauss TC; Bodziak KA; Aeder M; Siegel C; Schulak JA
    Transplantation; 2007 Feb; 83(3):277-81. PubMed ID: 17297401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes in African American kidney transplant recipients under contemporary immunosuppression: a four-yr analysis of the Mycophenolic acid Observational REnal transplant (MORE) study.
    Narayanan M; Pankewycz O; Shihab F; Wiland A; McCague K; Chan L
    Clin Transplant; 2014 Feb; 28(2):184-91. PubMed ID: 24372743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.